
---
title: '新冠药、新冠检测概念早盘逆市走强'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=9960'
author: 证券时报网
comments: false
date: Fri, 11 Mar 2022 09:42:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=9960'
---

<div>   
<p>证券时报e公司讯，新冠药、新冠检测概念早盘逆市走强，截至发稿， <a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002435" style="color: #2f67d1;text-decoration: none;" code="002435" target="_blank">长江健康</a>、美诺华、中国医药、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ000788" style="color: #2f67d1;text-decoration: none;" code="000788" target="_blank">北大医药</a>、兰卫医学、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002550" style="color: #2f67d1;text-decoration: none;" code="002550" target="_blank">千红制药</a>等均涨停。</p>

                  
</div>
            